Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 1;95(6):1104-1108.
doi: 10.1002/ccd.28408. Epub 2019 Aug 2.

The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris

Georgios Tzanis  1 , Anna Palmisano  2 , Guglielmo Gallone  1 , Francesco Ponticelli  1 , Luca Baldetti  1 , Antonio Esposito  2 , Antonio Colombo  1   3 , Francesco Giannini  1   3
Affiliations

The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris

Georgios Tzanis et al. Catheter Cardiovasc Interv. .

Abstract

Objectives: To evaluate the impact of coronary sinus (CS) Reducer implantation upon left ventricular (LV) function.

Background: CS Reducer implantation is associated with symptomatic relief in patients with refractory angina. The effects of the device upon left ventricular function remains unknown.

Methods: Prior to device implantation and at 4-months, resting ventricular volumes and function were measured using cardiac magnetic resonance (CMR). Stress CMR was performed to extract quantitative indices of myocardial perfusion (myocardial perfusion reserve index-MPRI).

Results: Nineteen patients (18 males, 66.0 [IQR 56.0-77.0] years), underwent successful Reducer implantation. Sixteen (84%) patients improved by at least 1 CCS class. Four months after Reducer implantation, we noticed a significant improvement in LV ejection fraction (LVEF) (61 [IQR 47-71] to 66 [IQR 57-72] %; p = .009), a reduction in LV end-diastolic volume (LVEDV)/Body surface area (BSA) (65.7 [IQR 57.4-89.6] to 64.7 [IQR 53.7-74.1] mL/m2 ; p = .036) and a reduction in LV end-systolic volume (LVESV)/BSA (28.7 [IQR 18.6-38.8] to 20.0 [IQR 15.0-31.4] mL/m2 ; p = .007). Patients with reduced EF (EF < 50%, n = 6) presented a greater increase of EF at follow up compared to patients with preserved EF (11.3 [IQR 6.5-54.5] vs. 3.8 [IQR 0.6-9.1] %; p = .029). The observed decrease in LVESV/BSA was greater in patients with reduced EF (23.6 [IQR 11.6-33.8] vs. 4.2 [IQR -2.0 to 8.4] mL/m2 ; p = .005). A significant increase in transmural MPRI was observed 4 months after Reducer implantation (p < .011).

Conclusions: CS Reducer improved angina symptoms and improved left ventricular function. The improvement was pronounced in the subgroup of patients with reduced ejection fraction. Myocardial perfusion improvement could represent the underlying mechanism for the observed benefits.

Keywords: cardiac magnetic resonance; coronary sinus reducer; ischemic cardiomyopathy; refractory angina; remodeling.

PubMed Disclaimer

Comment in

  • The Robin Hood effect!
    Jolicoeur EM, Henry TD. Jolicoeur EM, et al. Catheter Cardiovasc Interv. 2020 May 1;95(6):1109-1110. doi: 10.1002/ccd.28923. Catheter Cardiovasc Interv. 2020. PMID: 32421237

References

REFERENCES

    1. Beck CS, Stanton E, Batiuchok W, Leiter E. Revascularization of heart by graft of systemic artery into coronary sinus. JAMA. 1948;137(5):436-442.
    1. Verheye S, Jolicoeur EM, Behan MW, et al. Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med. 2015;372(6):519-527.
    1. Giannini F, Baldetti L, Ponticelli F, et al. Coronary sinus reducer implantation for the treatment of chronic refractory angina: a single-center experience. JACC Cardiovasc Interv. 2018;11(8):784-792.
    1. Gallone G, Baldetti L, Palmisano A, et al. Coronary sinus reducer implantation to reduce the ischemic burden in refractory angina. JACC Cardiovasc Interv. 2019;12(2):e11-e13.
    1. Konigstein M, Bazan S, Revivo M, Banai S. Coronary sinus reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-Centre experience. EuroIntervention. 2018;14(4):e452-e458.

MeSH terms

LinkOut - more resources